HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma

BACKGROUND: Early screening and detection of hepatocellular carcinoma (HCC) can efficiently improve patient prognosis. We aimed to identify a series of hypermethylated DNA markers and develop a blood-based HCC diagnosis panel containing DNA methylation sites and protein markers with improved sensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yi, Xu, Juan, Li, Deqiang, Zhang, Xiaoyu, Chen, Dapeng, Xie, Fucun, Huang, Longmei, Yu, Xiaotian, Zhao, Haitao, Zhang, Yamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258978/
https://www.ncbi.nlm.nih.gov/pubmed/37308980
http://dx.doi.org/10.1186/s13148-023-01508-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258978/
https://www.ncbi.nlm.nih.gov/pubmed/37308980
http://dx.doi.org/10.1186/s13148-023-01508-7

Ejemplares similares